Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults

NCT04219540 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

675

Enrollment

OTHER

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: XR-B (SUBLOCADETM)
DRUG: XR-NTX

Sponsor

NYU Langone Health

Collaborators

[object Object]